Teva Pharms. Int’l GmbH v. Eli Lilly & Co.

Objective indicia of nonobviousness must be linked to the unique characteristics of the claimed invention; secondary considerations resulting from something other than what is both claimed and novel lack the required nexus.

Generated summary for orientation only — not legal advice · medium confidence. Verify against the opinion.